Michelle Dizon, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4500 Sion Farm Suite 3b, Christiansted, VI 00820 Phone: 340-778-5780 Fax: 888-686-4557 |
News Archive
Thubrikar Aortic Valve, Inc., a privately held medical device company, today announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation system.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
AB SCIEX, a global leader in life science analytical technologies, today announced the formal opening of its Asia Pacific Application Support Center in Shanghai. With state-of-the-art, award-winning facilities, the new Application Support Center serves as a regional center of excellence for comprehensive service, support and application development to enable the science community in China and the region to continue its increasing use of mass spectrometry and complementary technologies for a broad range of applications.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
› Verified 2 days ago